ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02853318
Brief Title: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

First Submitted : July 29, 2016
First Submitted that Met QC Criteria : July 29, 2016
First Posted : August 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 3, 2018
Last Update Posted : May 4, 2018